Vitamin D receptor initiation codon polymorphism, bone density and inflammatory activity of patients with ankylosing spondylitis

Osteoporosis International

Volumn 14, Issue 12, 2003, Pages 995-1000

  Obermayer Pietsch, Barbara M ^a   Lange, Uwe ^b   Tauber, Gerlinde ^a   Frühauf, Gerwig ^a   Fahrleitner, Astrid ^a   Dobnig, Harald ^a   Hermann, Josef ^a   Aglas, Ferdinand ^a   Teichmann, Joachim ^b   Neeck, Gunter ^b   Leb, Georg ^a  

^a UNIVERSITY OF GRAZ   (Austria)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Ankylosing spondylitis; Bone mineral density; Osteoporosis; Vitamin D receptor polymorphisms

Indexed keywords

VITAMIN D RECEPTOR;

3' UNTRANSLATED REGION; ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; BONE DENSITY; BONE METABOLISM; BONE MINERAL; CODON; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE MARKER; DNA POLYMORPHISM; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR CONDYLE; FEMUR NECK; GENETIC ASSOCIATION; HUMAN; INFLAMMATORY INFILTRATE; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; SEX DIFFERENCE; START CODON; TRANSCRIPTION INITIATION;

ADULT; BLOOD SEDIMENTATION; BODY MASS INDEX; BONE DENSITY; C-REACTIVE PROTEIN; CODON, INITIATOR; DENSITOMETRY, X-RAY; FEMALE; FEMUR NECK; GENOTYPE; HLA-B27 ANTIGEN; HUMANS; LUMBAR VERTEBRAE; MALE; PAIN MEASUREMENT; POLYMORPHISM, GENETIC; RECEPTORS, CALCITRIOL; SEX FACTORS; SPONDYLITIS, ANKYLOSING;

EID: 1842539756     PISSN: 0937941X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00198-003-1501-5     Document Type: Article

References (38)

1. Will R, Palmer R, Bhalla AK, et al (1989) Osteoporosis in early ankylosing spondylitis: a primary pathological event? Lancet 2:1483-1485
2. Ralston SH, Urquhart GD, Brzeski M, et al (1990) Prevalence of vertebral compression fractures due to osteoporosis in ankylosing spondylitis. BMJ 300:563-565
3. Sivri A, Kilinc S, Gokce-Kutsal Y, et al (1996) Bone mineral density in ankylosing spondylitis. Clin Rheumatol 15:51-54
4. El Maghraoui A, Borderie D, Cherruau B, et al (1999) Osteoporosis, body composition, and bone turnover in ankylosing spondylitis. J Rheumatol 26:2205-2209
5. Donnelly S, Doyle DV, Denton A, et al (1994) Bone mineral density and vertebral compression fracture rates in ankylosing spondylitis. Ann Rheum Dis 53:117-121
6. Meirelles ES, Borelli A, Camargo OP (1999) Influence of disease activity and chronicity on ankylosing spondylitis bone mass loss. Clin Rheumatol 18:364-368
7. Kanis JA, Melton III LJ, Christiansen C, et al (1994) The diagnosis of osteoporosis. J Bone Min Res 9:1137-1141
8. Toussirot E, Nguyen NU, Dumoulin G, et al (1998) Insulin-like growth factor-1 and insulin-like growth factor binding protein-3 serum levels in ankylosing spondylitis. Br J Rheumatol 37:1172-1176
9. Bronson WD, Walker SE, Hillman LS, et al (1998) Bone mineral density and biochemical markers of bone metabolism in ankylosing spondylitis. J Rheumatol 25:929-935
10. Lange U, Jung O, Teichmann J, et al (2001) Relationship between disease activity and serum levels of vitamin D metabolites and parathyroid hormone in ankylosing spondylitis. Osteoporos Int 12:1031-1035
11. Obermayer-Pietsch BM, Fruhauf GE, Chararas K, et al (2000) Association of the vitamin D receptor genotype BB with low bone density in hyperthyroidism. J Bone Min Res 15:1950-1955
12. Gross C, Eccleshall TR, Malloy PJ, et al (1996) The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American woman. J Bone Min Res 11:1850-1855
13. Rizzoli R, Bonjour JP, Ferrari SL (2001) Osteoporosis, genetics and hormones. J Mol Endocrinol 26:79-94
14. Ferrari S, Rizzoli R, Manen D, et al (1998) Vitamin D receptor gene start codon polymorphisms (FokI) and bone mineral density: interaction with age, dietary calcium, and 3′-end region polymorphisms. J Bone Min Res 13:925-930
15. Harris S, Ross Eccleshall T, et al (1997) The vitamin D receptor start codon polymorphism (FokI) and bone mineral density in premenopausal American black and white woman. J Bone Min Res 12:1043-1048
16. Lau EM, Lam V, Li M, et al (2002) Vitamin D receptor start codon polymorphism (FokI) and bone mineral density in Chinese men and women. Osteoporos Int 13:218-221
17. Moll JM, Wright V (1973) New York clinical criteria for ankylosing spondylitis. A statistical evaluation. Ann Rheum Dis 32:354-363
18. Goie The HS, Steven MM, van der Linden SM, et al (1985) Evaluation of diagnostic criteria for ankylosing spondylitis: a comparison of the Rome, New York and modified New York criteria in patients with a positive clinical history screening test for ankylosing spondylitis. Br J Rheumatol 24:242-249
19. Garrett S, Jenkinson T, Kennedy LG, et al (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2289-2291
20. Pantazi H, Papapetrou PD (2000) Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism. J Clin Endocrinol Metab 85:1099-1106
21. Spittler A, Willheim M, Leumetzer F, et al (1997) Effects of 1 alpha, 25-dihydroxyvitamin D-3 and cytokines on the expression of MHC antigens, complement receptors and other antigens on human blood monocytes and U937 cells: role in cell differentiation, activation and phagocytosis. Immunology 90:286-293
22. 3 - involvement of NF-kappa B downregulation in transcriptional repression of the p40 gene. J Clin Invest 101:252-262
23. Larsson P, Mattsson L, Klareskog L, et al (1998) A vitamin D analogue ( MC1288) has immunomodulatory properties and suppresses collagen-induced arthritis (CIA) without causing hypercalcaemia. Clin Exp Immunol 114:277-283
24. Vogel A, Strassburg CP, Manns MP (2002) Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis. Hepatology 35):126-131
25. Simmons JD, Mullighan C, Welsh KI, et al (2000) Vitamin D receptor gene polymorphism: association with Crohn's disease susceptibility. Gut 47:211-214
26. Ban Y, Taniyama M, Yanagawa T, et al (2001) Vitamin D receptor initiation codon polymorphism influences genetic susceptibility to type 1 diabetes mellitus in the Japanese population. BMC Med Genet 2:7
27. Lange U (2000) Skeletal status in ankylosing spondylitis. J Rheumatol 27:4.27
28. Amento EP (1987) Vitamin D and the immune system. Steroids 49:55-72
29. Overbergh L, Decallonne B, Valckx D, et al (2000) Identification and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages. Clin Exp Immunol 120:139-146
30. Oelzner P, Müller A, Deschner F, et al (1998) Relationsship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis. Calcif Tiss Int 62:193-198
31. Lange U, Teichmann J, Stracke H (2000) Correlation between plasma TNF-alpha, IGF-1, biochemical markers of bone metabolism, markers of inflammation/disease activity, and clinical manifestations in ankylosing spondylitis. Eur J Med Res 5:507-511
32. Baeten D, Kruithof E, Van den Bosch F, et al (2001) Immunomodulatory effects of anti-tumor necrosis factor alpha therapy on synovium in spondylarthropathy: histologic findings in eight patients from an open-label pilot study. Arthritis Rheum 44:186-195
33. Quinn JM, Itoh K, Udagawa N (2001) Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions. J Bone Min Res 16:1787-1794
34. Fernandez-Martin JL, Kurian S, Farmer P et al (1998) Tumor necrosis factor activates a nuclear inhibitor of vitamin D and retinoid-X receptors. Mol Cell Endocrinol 25:65-72
35. Kuno H, Kurian SM, Hendy GN, et al (1994) Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element. Endocrinology 134:2524-2531
36. Schacht E (2000) Osteoporosis in rheumatoid arthritis: significance of alfacalcidol in prevention and therapy. Z Rheumatol 59:10-20
37. Shany S, Levy Y, Lahav-Cohen M (2001) The effects of 1alpha,24(S)- dihydroxyvitamin D(2) analog on cancer cell proliferation and cytokine expression. Steroids 66:319-325
38. Shiraishi A, Takeda S, Masaki T et al (2000) Alfacalcidol inhibits bone resorption and stimulates formation in an ovariectomized rat model of osteoporosis: distinct actions from estrogen. J Bone Min Res 15:770-779